The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Abstract
Objective Although psychological trauma affects millions of Americans, few studies have examined treatment of posttraumatic stress disorder (PTSD) in real-world service environments. This study explored pharmacological treatment of PTSD among privately insured individuals. Methods Data were from the MarketScan database, which compiles claims from private health insurance plans nationwide. Descriptive statistics and multivariate logistic regression were used to identify predictors of any use of a psychotropic medication and use of three medication classes: antidepressants, anxiolytics or sedative-hypnotics, and antipsychotics. Results Of 860,090 adult mental health care users in 2005, only 10,636 (1.2%) had a diagnosis of PTSD. Sixty percent of PTSD patients received any psychotropic medication: 74.3% of those received antidepressants, 73.7% received anxiolytics or sedative-hypnotics, and 21.3% received antipsychotics. Greater likelihood of any medication use was associated with greater use of mental health services and with several comorbid psychiatric disorders. Having a comorbid diagnosis of an indicated disorder was the most robust predictor of use of each of the three medication classes: major depressive disorder and dysthymia were most strongly associated with antidepressant use, schizophrenia and bipolar disorder were associated with antipsychotic use, and anxiety disorders were associated with use of anxiolytics or sedative-hypnotics. Conclusions Psychotropic medicatio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prior US study has reported frequent off-label medication use in routine clinical practice given the limited approved options for PTSD [27].”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [27]
In the citing paper
“Additional medications may also be used to treat PTSD-related symptoms that may not be routinely addressed but may have emerged during the course of PTSD [18,27], which can lead to polypharmacy.”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [27]
In the citing paper
“While the only medications approved for PTSD in the US are SSRIs (i.e.sertraline and paroxetine) [25], other medications may also be used off label [23,27]”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [27]
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
National Trends in the Outpatient Treatment of Depression
Olfson, M. (2002) · JAMA · doi:10.1001/jama.287.2.203 · Cited by 847
National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs
Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 591
Stein, M. B., Kline, N. A., & Matloff, J. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1777 · Cited by 347
Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R. M., & Austin, C. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00013 · Cited by 218
Clozapine Treatment in a Population of Adults With Mental Retardation
Antonacci, D. J., & de Groot, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0106 · Cited by 213
Low-Dose Risperidone as Adjunctive Therapy for Irritable Aggression in Posttraumatic Stress Disorder
Monnelly, E. P., Ciraulo, D. A., Knapp, C., & Keane, T. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00012 · Cited by 163
Hamner, M. B., Faldowski, R. A., Ulmer, H. G., Frueh, B. C., Huber, M. G., & Arana, G. W. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200301000-00001 · Cited by 162
Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Kudler, H. S., & Davidson, J. R. T. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009076231175 · Cited by 161
Olanzapine in the treatment of post-traumatic stress disorder: a pilot study
Butterfield, M. I., Becker, M. E., Connor, K. M., Sutherland, S., Churchill, L. E., & Davidson, J. R. T. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200107000-00003 · Cited by 160
Research works printed but not linked: 9
- 2005, c Visits and days in treatment are for
- Tjaden P, 1998, Thoennes N: Prevalence, Incidence and Consequences of Violence Against Women: Findings From the National Violence Against Women Survey
- Foa EB, 2000, Friedman M: Effective Treatments for PTSD: Practice Guideline From the International Society of Traumatic Stress Studies
- Van der Kolk BA, 1994, Journal of Clinical Psychiatry, 55, 517
- 10.3109/10401230009147096 · DOI · Paper page
- Braun P, 1990, Journal of Clinical Psychiatry, 51, 236
- Gelpin E, 1996, Journal of Clinical Psychiatry, 57, 390
- Stanton MW, 2004, Employer-sponsored health insurance: trends in cost and access. Research in Action [Agency for Healthcare Research and Quality], no
- Villarreal G, 2007, Psychopharmacology Bulletin, 40, 6
Cited by
Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis
GUINA, J., ROSSETTER, S. R., DeRHODES, B. J., NAHHAS, R. W., & WELTON, R. S. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000091 · Cited by 341
“In our literature review, we attempted to capture every available study about BZDs in PTSD to examine 3 questions: (1) What are the effects of BZDs on the development of PTSD in trauma patients? (2) What are the effects of BZDs on PTSD-associated outcomes in patients with PTSD? (3) What are the effects of BZDs on PTSD…”
MethodBenzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Guina, J., & Merrill, B. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020017 · Cited by 253
“Unfortunately, some of these factors—particularly SUDs and borderline personality disorder—also correlate with increased BZD prescriptions [20,22,23,25,26].”
BackgroundResultInfluentialFeder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20050596 · Cited by 246
“Approximately 60% of patients with PTSD respond to SSRIs, and only 20% 2 30% achieve complete remission following pharmacotherapy (7), resulting in poly ‐ pharmacy in clinical practice (8, 9).”
BackgroundFoa, E. B., Gillihan, S. J., & Bryant, R. A. (2013) · Psychological Science in the Public Interest · doi:10.1177/1529100612468841 · Cited by 222
Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence
Nappi, C. M., Drummond, S. P. A., & Hall, J. M. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.029 · Cited by 153
“Sedative hypnotics Though benzodiazepines and sedative hypnotics are commonly used in patients with PTSD (Harpaz-Rotem et al., 2008; Mohamed and Rosenheck, 2008), few studies have examined the efficacy of benzodiazepines for treatment of sleep disturbance in PTSD.”
Background
Metadata
- Authors
- Harpaz-Rotem, I., Rosenheck, R. A., Mohamed, S., & Desai, R. A.
- Venue
- Psychiatric Services
- Published
- 2008-10
- Volume
- 59
- Issue
- 10
- Pages
- 1184-1190
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- OpenAlex
- W4233357649
- Cited by
- 51
- References
- 25
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 1 · 2013: 4 · 2012: 6
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- post-traumatic stress disorder, pharmacotherapy, antidepressants, private health insurance, treatment utilization
- MeSH terms
- Adult, Female, Humans, Insurance, Health, Male, Middle Aged, Stress Disorders, Post-Traumatic, United States, Comorbidity, Logistic Models, Private Sector, Insurance Coverage, Health Care Surveys, Databases as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans. https://app.cochat.ai/papers/10.1176/ps.2008.59.10.1184
- The paper
- Harpaz-Rotem, I., Rosenheck, R. A., Mohamed, S., & Desai, R. A. (2008). Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans. Psychiatric Services. https://doi.org/10.1176/ps.2008.59.10.1184
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.